Table 1.
Marker 1 | Correlation 2 | R2; p-Value 3 |
---|---|---|
Ki-67 | + | 0.5; <0.01 |
CPT1 | - | 0.5; <0.01 |
SLC22A2 | - | 0.5; 0.005 |
SLC22A5 | + | 0.8; <0.001 |
SLC25A20 | + | 0.6; 0.001 |
1 Tumor proliferation (Ki-67) and lipid metabolism-associated protein expression (CPT1, SLC22A2, SLC22A5, SLS25A20) were assessed using immunohistochemistry. 2 Significant correlations between [18F]FPIA tumor uptake and marker expression shown as (+), positive and (-), negative. 3 Pearson linear regression analyses.